Rogier E. Ooijevaar

2.0k total citations · 1 hit paper
18 papers, 1.2k citations indexed

About

Rogier E. Ooijevaar is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Rogier E. Ooijevaar has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 8 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Rogier E. Ooijevaar's work include Clostridium difficile and Clostridium perfringens research (13 papers), Microscopic Colitis (7 papers) and Nosocomial Infections in ICU (4 papers). Rogier E. Ooijevaar is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (13 papers), Microscopic Colitis (7 papers) and Nosocomial Infections in ICU (4 papers). Rogier E. Ooijevaar collaborates with scholars based in Netherlands, Denmark and Austria. Rogier E. Ooijevaar's co-authors include Josbert J. Keller, Ed J. Kuijper, Elisabeth M. Terveer, Hein W. Verspaget, Abraham Goorhuis, Karuna E.W. Vendrik, E. Kuijper, Joffrey van Prehn, Jacobus J. van Hilten and Jon D. Laman and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Rogier E. Ooijevaar

17 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults

2021 354 citations Joffrey van Prehn, Elena Reigadas et al. Clinical Microbiology and Infection profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rogier E. Ooijevaar Netherlands	12	754	579	421	274	201	18	1.2k
Tanya Monaghan United Kingdom	20	733 1.0×	658 1.1×	456 1.1×	187 0.7×	230 1.1×	61	1.6k
Olga C. Aroniadis United States	19	1.2k 1.6×	872 1.5×	661 1.6×	760 2.8×	400 2.0×	50	1.9k
Ari Grinspan United States	16	476 0.6×	464 0.8×	296 0.7×	215 0.8×	178 0.9×	45	922
Takehide Fujimoto Japan	13	215 0.3×	628 1.1×	270 0.6×	157 0.6×	211 1.0×	30	1.2k
Kate E. Mackin Australia	11	653 0.9×	329 0.6×	340 0.8×	79 0.3×	164 0.8×	15	1.0k
Guozhong Ji China	24	983 1.3×	1.2k 2.0×	510 1.2×	539 2.0×	411 2.0×	53	2.1k
M. Alaric Franzos United States	4	571 0.8×	386 0.7×	303 0.7×	249 0.9×	139 0.7×	8	752
Ramesh Paramsothy Australia	9	1.0k 1.4×	1.3k 2.2×	520 1.2×	488 1.8×	284 1.4×	15	1.8k
Chun Xiang Tang China	19	271 0.4×	538 0.9×	162 0.4×	69 0.3×	326 1.6×	56	1.2k
Cicilia Marcella China	9	323 0.4×	406 0.7×	250 0.6×	177 0.6×	133 0.7×	16	869

Countries citing papers authored by Rogier E. Ooijevaar

Since Specialization

Citations

This map shows the geographic impact of Rogier E. Ooijevaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rogier E. Ooijevaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rogier E. Ooijevaar more than expected).

Fields of papers citing papers by Rogier E. Ooijevaar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rogier E. Ooijevaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rogier E. Ooijevaar. The network helps show where Rogier E. Ooijevaar may publish in the future.

Co-authorship network of co-authors of Rogier E. Ooijevaar

This figure shows the co-authorship network connecting the top 25 collaborators of Rogier E. Ooijevaar. A scholar is included among the top collaborators of Rogier E. Ooijevaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rogier E. Ooijevaar. Rogier E. Ooijevaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Ooijevaar, Rogier E., et al.. (2023). A case of parotitis caused by hMPX virus. The Lancet. 401(10374). e17–e17. 2 indexed citations

Ooijevaar, Rogier E., Els Wessels, Mariet C.W. Feltkamp, et al.. (2022). How to prepare stool banks for an appropriate response to the ongoing COVID-19 pandemic: Experiences in the Netherlands and a retrospective comparative cohort study for faecal microbiota transplantation. PLoS ONE. 17(3). e0265426–e0265426. 2 indexed citations

Vendrik, Karuna E.W., Tim G. J. de Meij, Arend Bökenkamp, et al.. (2022). Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening?. Open Forum Infectious Diseases. 9(7). ofac324–ofac324. 8 indexed citations

Rossen, Tessel M. van, Rogier E. Ooijevaar, Johan P. Kuyvenhoven, et al.. (2021). Microbiota composition and mucosal immunity in patients with asymptomatic diverticulosis and controls. PLoS ONE. 16(9). e0256657–e0256657. 12 indexed citations

Rossen, Tessel M. van, Rogier E. Ooijevaar, Christina M. J. E. Vandenbroucke‐Grauls, et al.. (2021). GRADING prognostic factors for severe and recurrent Clostridioides difficile infection: expected and unexpected findings. A systematic review. medRxiv.

Prehn, Joffrey van, Elena Reigadas, Erik Vogelzang, et al.. (2021). European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clinical Microbiology and Infection. 27. S1–S21. 354 indexed citations breakdown →

Rossen, Tessel M. van, Rogier E. Ooijevaar, Christina M. J. E. Vandenbroucke‐Grauls, et al.. (2021). Prognostic factors for severe and recurrent Clostridioides difficile infection: a systematic review. Clinical Microbiology and Infection. 28(3). 321–331. 32 indexed citations

Ooijevaar, Rogier E., Els van Nood, Abraham Goorhuis, et al.. (2021). Ten-Year Follow-Up of Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection from a Randomized Controlled Trial and Review of the Literature. Microorganisms. 9(3). 548–548. 14 indexed citations

Terveer, Elisabeth M., Karuna E.W. Vendrik, Rogier E. Ooijevaar, et al.. (2020). Faecal microbiota transplantation for Clostridioides difficile infection: Four years’ experience of the Netherlands Donor Feces Bank. United European Gastroenterology Journal. 8(10). 1236–1247. 35 indexed citations

10.

Vendrik, Karuna E.W., Elisabeth M. Terveer, Ed J. Kuijper, et al.. (2020). Periodic screening of donor faeces with a quarantine period to prevent transmission of multidrug-resistant organisms during faecal microbiota transplantation: a retrospective cohort study. The Lancet Infectious Diseases. 21(5). 711–721. 35 indexed citations

11.

Vendrik, Karuna E.W., Rogier E. Ooijevaar, Jon D. Laman, et al.. (2020). Fecal Microbiota Transplantation in Neurological Disorders. Frontiers in Cellular and Infection Microbiology. 10. 98–98. 289 indexed citations

12.

Ooijevaar, Rogier E., et al.. (2019). Botox treatment in patients with chronic functional anorectal pain: experiences of a tertiary referral proctology clinic. Techniques in Coloproctology. 23(3). 239–244. 11 indexed citations

13.

Ooijevaar, Rogier E., Tessel M. van Rossen, Christina M. J. E. Vandenbroucke‐Grauls, et al.. (2019). [Faecal transplants for children with recurrent infections].. PubMed. 163. 1 indexed citations

14.

Terveer, Elisabeth M., Tom van Gool, Rogier E. Ooijevaar, et al.. (2019). Human Transmission of Blastocystis by Fecal Microbiota Transplantation Without Development of Gastrointestinal Symptoms in Recipients. Clinical Infectious Diseases. 71(10). 2630–2636. 35 indexed citations

15.

Ooijevaar, Rogier E., Yvette H. van Beurden, Elisabeth M. Terveer, et al.. (2018). Update of treatment algorithms for Clostridium difficile infection. Clinical Microbiology and Infection. 24(5). 452–462. 92 indexed citations

16.

Ooijevaar, Rogier E., Elisabeth M. Terveer, Hein W. Verspaget, Ed J. Kuijper, & Josbert J. Keller. (2018). Clinical Application and Potential of Fecal Microbiota Transplantation. Annual Review of Medicine. 70(1). 335–351. 244 indexed citations

17.

Nijeboer, Petula, Tom van Gils, Martine Reijm, et al.. (2018). Gamma-Delta T Lymphocytes in the Diagnostic Approach of Coeliac Disease. Journal of Clinical Gastroenterology. 53(5). e208–e213. 26 indexed citations

18.

Bahce, Idris, Marc C. Huisman, Eline E. Verwer, et al.. (2014). Pilot study of 89Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancer. EJNMMI Research. 4(1). 35–35. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact